市場調查報告書

切片設備的全球市場 - 產業分析及市場預測(2017年∼2022年)

Biopsy Devices Market - Growth, Trends, and Forecast (2019 - 2024)

出版商 Mordor Intelligence LLP 商品編碼 390605
出版日期 內容資訊 英文 114 Pages
商品交期: 2-3個工作天內
價格
切片設備的全球市場 - 產業分析及市場預測(2017年∼2022年) Biopsy Devices Market - Growth, Trends, and Forecast (2019 - 2024)
出版日期: 2019年03月01日內容資訊: 英文 114 Pages
簡介

切片設備的全球市場,2014年估量為16億美元,預計從2014年2021年的預測期間將以7.1%的年複合成長率成長,到2020年達到24億1,400萬美元的規模。切片檢查,判斷檢查組織或細胞受到影響的組織,並從體內除去。進行做如果採為了有患者癌症的疑問,診斷及癌症判斷組織樣品切片檢查。這個程序,為了查出癌症由介入性放射學者進行。這個市場終端用戶,是醫院,診斷中心,及其他的診療所。

本報告提供全球切片設備市場調查,整體市場趨勢,各產品、地區的詳細趨勢,市場成長的影響要素分析,競爭情形,主要企業簡介等,總括性彙整。

目錄

第1章 簡介

  • 關於報告
  • 調查方法
  • 相關利益者

第2章 摘要整理

  • 主要的觀察
  • 市場概要

第3章 市場概況

  • 市場定義
    • 簡介
    • 切片檢查定義
    • 切片檢查為何進行?
    • 切片檢查識別症狀的條件
    • 切片檢查的類型
  • 市場成長要素
    • 一般認識的提高
    • 癌症人口的增加
    • 篩檢檢驗的增加
    • 新興市場
  • 市場阻礙因素
    • 設備成本

第4章 全球市場:各設備類型市場區隔

  • 針頭
  • 刮匙
  • 打洞器
  • 鉗子
  • 噴槍
  • 自動切片設備

第5章 全球市場:各地理市場區隔

  • 北美
    • 美國
    • 加拿大
  • 歐洲
    • 英國
    • 法國
    • 德國
    • 西班牙
  • 亞太地區
    • 中國
    • 韓國
    • 印度
    • 日本
  • 其他地區
    • 巴西
    • 中東
    • 澳洲

第6章 競爭情形

  • 簡介
  • M&A
  • 擴張
  • 新產品的銷售
  • 合作

第7章 企業簡介

  • CR Bard
  • Hologic
  • Carefusion
  • Devicor Medical Products
  • Cook Medical
  • Boston Scientific
  • Intact Medical Corporation
  • Gallini Medical Devices
  • TSK Laboratory

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: 52928

Market Overview

The propelling factors for the growth of the biopsy devices market include the increasing preference for minimally invasive procedures, an increase in the number of cancer cases worldwide, and initiatives undertaken by the government for diagnosis.

Biopsy has been one of the major diagnosis techniques for cancer disorders and is widely used in the diagnosis of breast, skin, and prostate cancer. According to the World Cancer Report, cancer rates could further increase by 50% to 15 million new cases by 2020. Therefore, with the increasing incidence of cancer cases and developments in the biopsy devices, the market is expected to increase in the forecast period.

There is also a demand for minimally invasive biopsy procedures that is rising at a significant rate in the market. The different types of technologies and products, such as biopsy guiding systems, needle-based biopsy guns, and vacuum assisted devices are anticipated to witness the high growth during the forecast period.

In addition, the growing awareness regarding breast cancer treatment and diagnosis will support the increase in the biopsy devices market size in the upcoming years. There are many countries that hold programs for the early diagnosis of breast cancer. Therefore, such initiatives will accelerate the adoption rate of biopsy devices, thereby positively impacting the growth of the biopsy devices business in the foreseeable future.

Scope of the Report

As per the scope of the report, a biopsy is a process that helps in the removal of tissue from an organ to determine the presence or extent of disease, mostly cancerous and inflammatory conditions. This diagnostic procedure is generally performed by surgeons, radiologists, and interventional cardiologists, to confirm the presence of cancerous tissues. Therefore, the biopsy procedures can be performed for almost any organ with the help of a specific biopsy device.

Key Market Trends

Needle-based Biopsy Instruments is the Largest Segment Under Products that is Expected to Grow During the Forecast Period

Needle-based biopsy holds the leading share in the market due to the increasing demand for these instruments, for acquiring samples from soft tissues of internal organs, such as breasts, kidneys, and lungs. This is poised to contribute to the growth of the overall market during the forecast period. Hence, the above benefits of needle-based biopsy guns coupled with the increasing demand for minimally invasive procedures will spur the segmental growth.

North America Holds the Largest Share and is Expected to Follow the Same Trend Over the Forecast Period

North America is found to be the leading revenue contributor in the market. The established market players in the region will continue to account for a substantial share in the market throughout the forecast period. The number of biopsies performed in the United States is also found to be the highest, helping in the expansion of the overall market. Furthermore, sophisticated healthcare infrastructure and the growing prevalence of infections will positively impact the biopsy devices growth over the projected timeframe.

Competitive Landscape

The major market players operating in the biopsy devices market are Hologic, C.R. Bard Inc., Devicor Medical Products Inc., among other players. These companies are undertaking strategies, such as product launch through technological innovations and partnerships to gain profits in the industry. Thus, the new product launches are the most preferred strategy followed by collaborations and geographical expansion for market capitalization.

Reasons to Purchase this report:

  • The market estimate (ME) sheet in Excel format
  • Report customization as per the client's requirements
  • 3 months of analyst support

Table of Contents

1 INTRODUCTION

  • 1.1 Study Deliverables
  • 1.2 Study Assumptions
  • 1.3 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Increasing Preference for Minimally Invasive Procedures
    • 4.2.2 Increase in the Number of Cancer Cases Worldwide
    • 4.2.3 Initiatives Undertaken by Government for Diagnosis
  • 4.3 Market Restraints
    • 4.3.1 Product Recalls
    • 4.3.2 Availability of Alternative Techniques
  • 4.4 Porter's Five Forces Analysis
    • 4.4.1 Threat of New Entrants
    • 4.4.2 Bargaining Power of Buyers/Consumers
    • 4.4.3 Bargaining Power of Suppliers
    • 4.4.4 Threat of Substitute Products
    • 4.4.5 Intensity of Competitive Rivalry

5 MARKET SEGMENTATION

  • 5.1 By Product
    • 5.1.1 Needle-based Biopsy Instruments
      • 5.1.1.1 Core Biopsy Devices
      • 5.1.1.2 Aspiration Biopsy Needles
      • 5.1.1.3 Vacuum-assisted Biopsy Devices
    • 5.1.2 Procedure Trays
    • 5.1.3 Localization Wires
    • 5.1.4 Other Products
  • 5.2 By Application
    • 5.2.1 Breast Biopsy
    • 5.2.2 Lung Biopsy
    • 5.2.3 Colorectal Biopsy
    • 5.2.4 Prostate Biopsy
    • 5.2.5 Other Applications
  • 5.3 Geography
    • 5.3.1 North America
      • 5.3.1.1 US
      • 5.3.1.2 Canada
      • 5.3.1.3 Mexico
    • 5.3.2 Europe
      • 5.3.2.1 Germany
      • 5.3.2.2 UK
      • 5.3.2.3 France
      • 5.3.2.4 Italy
      • 5.3.2.5 Spain
      • 5.3.2.6 Rest of Europe
    • 5.3.3 Asia-Pacific
      • 5.3.3.1 China
      • 5.3.3.2 Japan
      • 5.3.3.3 India
      • 5.3.3.4 Australia
      • 5.3.3.5 South Korea
      • 5.3.3.6 Rest of Asia-Pacific
    • 5.3.4 Middle East & Africa
      • 5.3.4.1 GCC
      • 5.3.4.2 South Africa
      • 5.3.4.3 Rest of Middle East & Africa
    • 5.3.5 South America
      • 5.3.5.1 Brazil
      • 5.3.5.2 Argentina
      • 5.3.5.3 Rest of South America

6 COMPETITIVE LANDSCAPE

  • 6.1 Company Profiles
    • 6.1.1 Becton, Dickinson and Company
    • 6.1.2 Hologic Inc.
    • 6.1.3 Devicor Medical Products Inc.
    • 6.1.4 Cook Medical
    • 6.1.5 Boston Scientific Corporation
    • 6.1.6 Intact Medical Corporation
    • 6.1.7 Gallini Medical
    • 6.1.8 TSK Laboratory Europe BV
    • 6.1.9 Argon Medical Devices

7 MARKET OPPORTUNITIES AND FUTURE TRENDS